Navigation Links
Nasty 'superbug' is being studied by UB researchers
Date:2/17/2012

BUFFALO, N.Y. -- University at Buffalo researchers are expressing concern about a new, under-recognized, much more potent variant of a common bacterium that has surfaced in the U.S.

"Historically, in Western countries, classical strains of Klebsiella pneumoniae have caused infections mostly in sick, hospitalized patients whose host defense systems are compromised," says Thomas Russo, MD, professor in the Department of Medicine at the UB School of Medicine and Biomedical Sciences and head of its Infectious Disease Division. A photograph of Russo is here: http://www.buffalo.edu/news/13200

"But in the last 10 to 15 years, a new variant of it has begun causing community-acquired infection in young, healthy individuals," he says. "This variant causes serious, life-threatening, invasive infections and is able to spread to other organs from the initial site of infection."

Perhaps most important, says Russo, these hypervirulent strains of Klebsiella pneumoniae have the potential to become highly resistant to antibiotics, similar to Escherichia coli and classical Klebsiella pneumoniae.

"These hypervirulent strains are the next 'superbugs' in-waiting," he says. "If they become resistant to antibiotics, they will become difficult, if not impossible to treat."

With recent funding from the National Institutes of Health under a program to fund high-risk, high-reward research, Russo and his UB colleagues are studying the microbiology of the new variant of Klebsiella pneumoniae in an effort to identify the genes that make it hypervirulent so they can figure out how to stop it in its tracks.

"Infections due to highly resistant bacteria are becoming increasingly problematic," says Russo. "We are continually threatened by a 'post-antibiotic' era. The combination of a bacterium that is both highly virulent and resistant to antimi
'/>"/>

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-4605
University at Buffalo
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Beating superbugs with a high-tech cleanser
2. Left-handed iron corkscrews point the way to new weapon in battle against superbugs like MRSA
3. Roads pave the way for the spread of superbugs
4. Aggressive drug therapy aids superbug evolution
5. Communication pathways within proteins may yield new drug targets to stop superbugs
6. Tufts researcher elected 2010 AAAS Fellow for work in superbugs and heat-stable vaccines
7. New Drug-Resistant Superbug Reaches U.S. Shores
8. Travel for Surgery May Help Spread New Superbug
9. New superbug surpasses MRSA infection rates in community hospitals
10. Many babies born to immigrants are being labeled too small incorrectly
11. Being Fit Before Stroke May Aid Recovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Consumer injury attorney Michael J. Evans announced ... launched a new website for people who believe they ... is http://www.DialysisLawsuitAttorneys.com . , "My litigation partners and ... services to people who may have been injured by ... may have suffered injuries due to some other form ...
(Date:6/18/2013)... 2013 "What if adding one simple ... boost your health and well-being? Well, there is something ... Beauty®. "It is called Skin Brushing ." , ... a lost art. Now, people are rediscovering this great ... and so do certain health conscious people. Sublime Beauty® ...
(Date:6/18/2013)... 2013 Looking for a way to break ... life? , IWALKAWAKE is a guide to unlocking one’s ... Botha, it focuses on harnessing the powerful and abundant spiritual ... out a nine-step guide to finding one’s true purpose and ... must go through to reach their true potential. The awakenings ...
(Date:6/18/2013)... SEATTLE, WA—A Washington state resident filed ... claiming he fell ill with a hepatitis A infection ... blend. The complaint was filed in Snohomish County ... Seattle-based law firm that has filed 14 previous ... complaint, Brian Brothers consumed “Townsend Farms Organic Antioxidant Blend” ...
(Date:6/18/2013)... Horsham, PA (PRWEB) June 18, 2013 Senior ... in Boston on June 25 to discuss—for the first time ... agencies in getting drugs through the regulatory process in a ... of drug evaluation will share respective best practices and processes ... Across the Strait panel at the DIA 2013 ...
Breaking Medicine News(10 mins):Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 2Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 3Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 4Health News:The Easiest Way to Contribute to Better Health and Well-Being Starting Today and for Under $20, Says Sublime Beauty® 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2
... A growing number of Americans know about chronic obstructive pulmonary ... disease, a new survey has found. According to the ... knew about COPD, a 4 percent increase from 2008. Awareness ... results were released this week by the U.S. National Heart, ...
... (Geneva, Switzerland) A Pneumonia Report Card released today ... of the Global Coalition against Child Pneumonia reveals where ... coverage for the life-saving interventions that can prevent, protect ... is the world,s leading infectious killer of young children, ...
... A new study from researchers in Colorado shows that women ... a screening colonoscopy than those who were not offered this ... to be common among women. In this study, a patient ... screening colonoscopy can be increased by offering women the option ...
... 11, 2010 The November 2010 issue of the ... Journal of the American Congress of Rehabilitation Medicine, has ... injury (TBI) that will accelerate future research in the ... injury, how it is measured and classified, treatment and ...
... 11 (HealthDay News) -- Diabetes is a leading cause of ... the risk factors and what they can do to prevent ... "Diabetes is a chronic condition that can cause serious ... kidney failure and nervous system damage," ACP President Dr. J. ...
... release is available in French . , Montreal, ... should receive an additional cardiac test when undergoing diagnosis for ... University, the Universit du Qubec Montral and the Montreal ... in the Journal of Cardiopulmonary Rehabilitation and Prevention , ...
Cached Medicine News:Health News:Awareness of COPD Growing, But More Lung Testing Urged 2Health News:Efforts to combat pneumonia among 15 high-burdened countries fall short of recommended targets 2Health News:Efforts to combat pneumonia among 15 high-burdened countries fall short of recommended targets 3Health News:Screening colonoscopy rates are not increased when women are offered a female endoscopist 2Health News:Screening colonoscopy rates are not increased when women are offered a female endoscopist 3Health News:Screening colonoscopy rates are not increased when women are offered a female endoscopist 4Health News:Consensus on TBI and PTSD will accelerate future research and improve patient care 2Health News:Consensus on TBI and PTSD will accelerate future research and improve patient care 3Health News:Consensus on TBI and PTSD will accelerate future research and improve patient care 4Health News:Consensus on TBI and PTSD will accelerate future research and improve patient care 5Health News:Consensus on TBI and PTSD will accelerate future research and improve patient care 6Health News:Are You at Risk of Developing Diabetes? 2Health News:Additional cardiac testing vital for patients with anxiety and depression 2
(Date:6/18/2013)... NEW YORK , June 18, 2013 JDRF ... ) are accelerating the development of new products that combine ... new collaboration announced today. This new, three-year commitment is an ... (T1D). Many patients with T1D not only take ... to be placed in the body for a number of ...
(Date:6/18/2013)... , June 18, 2013 Today, ... Inc. (NASDAQ: GILD ), Health Management Associates Inc. ... IDXX ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ... access these reports free of charge - including full price ... below. Gilead Sciences, Inc. Research Report ...
(Date:6/18/2013)... , June 18, 2013 Remedy ... for healthcare and life sciences research, today announced ... Administration (GSA) IT Schedule 70 supply contract (GS-35F-367AA, ... to provide innovative IT solutions to government agencies ... with this contract, Remedy has placed its products ...
Breaking Medicine Technology:JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4
... Dec. 14 Results from a Phase 3 ... were treated previously with,an anthracycline in the adjuvant ... progression (TTP) and overall response rates after,receiving a ... as compared to docetaxel alone. , ...
... bioMerieux company,that discovers, develops and commercializes new molecular ... studies using the company,s,molecular breast cancer assay to ... from the studies were presented this week at ... The Theros Breast ...
Cached Medicine Technology:Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer 2Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer 3Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer 4Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer 5Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer 6Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer 7Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer 8Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium 2Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium 3Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: